Amelia Heslington, Catharien M. U. Hilkens, Ana Marina Ferreira, Priscila Melo
{"title":"人类疾病和炎症背景下基于滑膜功能的3D模型","authors":"Amelia Heslington, Catharien M. U. Hilkens, Ana Marina Ferreira, Priscila Melo","doi":"10.1002/anbr.202500029","DOIUrl":null,"url":null,"abstract":"<p>The synovium plays a crucial role in joint function and is a primary site of pathology in inflammatory joint diseases, such as rheumatoid arthritis (RA). Immune-mediated inflammatory diseases (IMIDs), including RA, are becoming increasingly prevalent worldwide. However, the development of effective treatments remains hindered by the limitations of preclinical modeling techniques. Traditional methods, such as 2D in vitro monolayer cultures and animal models, often fail to replicate the complexity of human tissues. To address these challenges, tissue engineering (TE) and biofabrication strategies have emerged as promising alternatives. These approaches enable the creation of 3D in vitro models that better mimic physiological conditions. Techniques like 3D bioprinting allow researchers to replicate cellular interactions and the extracellular matrix, improving the accuracy of disease models. The application of 3D models in therapy development, drug screening, and personalized medicine has grown significantly. These platforms offer valuable insights into IMID pathophysiology by simulating relevant microenvironments. This review examines current synovium models used in IMID research and explores future directions in TE and 3D biofabrication. Additionally, the impact of inflammation on tissues and discuss the clinical potential of 3D disease models to address current disregarded aspects of coexistent diseases is highlighted.</p>","PeriodicalId":29975,"journal":{"name":"Advanced Nanobiomed Research","volume":"5 7","pages":""},"PeriodicalIF":4.4000,"publicationDate":"2025-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/anbr.202500029","citationCount":"0","resultStr":"{\"title\":\"Functional Synovium-Based 3D Models in the Context of Human Disease and Inflammation\",\"authors\":\"Amelia Heslington, Catharien M. U. Hilkens, Ana Marina Ferreira, Priscila Melo\",\"doi\":\"10.1002/anbr.202500029\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>The synovium plays a crucial role in joint function and is a primary site of pathology in inflammatory joint diseases, such as rheumatoid arthritis (RA). Immune-mediated inflammatory diseases (IMIDs), including RA, are becoming increasingly prevalent worldwide. However, the development of effective treatments remains hindered by the limitations of preclinical modeling techniques. Traditional methods, such as 2D in vitro monolayer cultures and animal models, often fail to replicate the complexity of human tissues. To address these challenges, tissue engineering (TE) and biofabrication strategies have emerged as promising alternatives. These approaches enable the creation of 3D in vitro models that better mimic physiological conditions. Techniques like 3D bioprinting allow researchers to replicate cellular interactions and the extracellular matrix, improving the accuracy of disease models. The application of 3D models in therapy development, drug screening, and personalized medicine has grown significantly. These platforms offer valuable insights into IMID pathophysiology by simulating relevant microenvironments. This review examines current synovium models used in IMID research and explores future directions in TE and 3D biofabrication. Additionally, the impact of inflammation on tissues and discuss the clinical potential of 3D disease models to address current disregarded aspects of coexistent diseases is highlighted.</p>\",\"PeriodicalId\":29975,\"journal\":{\"name\":\"Advanced Nanobiomed Research\",\"volume\":\"5 7\",\"pages\":\"\"},\"PeriodicalIF\":4.4000,\"publicationDate\":\"2025-04-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/anbr.202500029\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Advanced Nanobiomed Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://advanced.onlinelibrary.wiley.com/doi/10.1002/anbr.202500029\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ENGINEERING, BIOMEDICAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advanced Nanobiomed Research","FirstCategoryId":"1085","ListUrlMain":"https://advanced.onlinelibrary.wiley.com/doi/10.1002/anbr.202500029","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
Functional Synovium-Based 3D Models in the Context of Human Disease and Inflammation
The synovium plays a crucial role in joint function and is a primary site of pathology in inflammatory joint diseases, such as rheumatoid arthritis (RA). Immune-mediated inflammatory diseases (IMIDs), including RA, are becoming increasingly prevalent worldwide. However, the development of effective treatments remains hindered by the limitations of preclinical modeling techniques. Traditional methods, such as 2D in vitro monolayer cultures and animal models, often fail to replicate the complexity of human tissues. To address these challenges, tissue engineering (TE) and biofabrication strategies have emerged as promising alternatives. These approaches enable the creation of 3D in vitro models that better mimic physiological conditions. Techniques like 3D bioprinting allow researchers to replicate cellular interactions and the extracellular matrix, improving the accuracy of disease models. The application of 3D models in therapy development, drug screening, and personalized medicine has grown significantly. These platforms offer valuable insights into IMID pathophysiology by simulating relevant microenvironments. This review examines current synovium models used in IMID research and explores future directions in TE and 3D biofabrication. Additionally, the impact of inflammation on tissues and discuss the clinical potential of 3D disease models to address current disregarded aspects of coexistent diseases is highlighted.
期刊介绍:
Advanced NanoBiomed Research will provide an Open Access home for cutting-edge nanomedicine, bioengineering and biomaterials research aimed at improving human health. The journal will capture a broad spectrum of research from increasingly multi- and interdisciplinary fields of the traditional areas of biomedicine, bioengineering and health-related materials science as well as precision and personalized medicine, drug delivery, and artificial intelligence-driven health science.
The scope of Advanced NanoBiomed Research will cover the following key subject areas:
▪ Nanomedicine and nanotechnology, with applications in drug and gene delivery, diagnostics, theranostics, photothermal and photodynamic therapy and multimodal imaging.
▪ Biomaterials, including hydrogels, 2D materials, biopolymers, composites, biodegradable materials, biohybrids and biomimetics (such as artificial cells, exosomes and extracellular vesicles), as well as all organic and inorganic materials for biomedical applications.
▪ Biointerfaces, such as anti-microbial surfaces and coatings, as well as interfaces for cellular engineering, immunoengineering and 3D cell culture.
▪ Biofabrication including (bio)inks and technologies, towards generation of functional tissues and organs.
▪ Tissue engineering and regenerative medicine, including scaffolds and scaffold-free approaches, for bone, ligament, muscle, skin, neural, cardiac tissue engineering and tissue vascularization.
▪ Devices for healthcare applications, disease modelling and treatment, such as diagnostics, lab-on-a-chip, organs-on-a-chip, bioMEMS, bioelectronics, wearables, actuators, soft robotics, and intelligent drug delivery systems.
with a strong focus on applications of these fields, from bench-to-bedside, for treatment of all diseases and disorders, such as infectious, autoimmune, cardiovascular and metabolic diseases, neurological disorders and cancer; including pharmacology and toxicology studies.